Navigation path

Pharmaceuticals - Community Register


List of nationally authorised medicinal products for human use

Clopidogrel Teva and associated names

Product name: Clopidogrel Teva and associated names
Also marketed in the EU under the name(s): Alvadavix, Clopidogrel, Clopidogrel Dr. Reddy´s, Clopidophar, Clopix, Teclop, Tevaplat, Xoval
Active substance: Clopidogrel
Indication: indicated in adults for the prevention of atherothrombic events in: *patients suffering from myocardial infarction; ischaemic stroke; established peripheral arterial disease and *patients suffering from acute coronary syndrome
Marketing Authorisation Holder: Teva Pharma B.V.

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
07/06/2010 Referral EMEA/H/A-29/1246 (2010)3712 of 04/06/2010